Skip to main content
Clinical Trials/NCT07614217
NCT07614217Not yet recruitingNot Applicable

Effectiveness of a Structured Oral Health Educational Program on Oral Hygiene and Oral Health Related Quality of Life in Children With β-Thalassemia Major: Before and After Interventional Study.

Cairo University0 sites45 target enrollmentStarted: November 1, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
45

Study Overview

Brief Summary

To evaluate the effectiveness of a structured oral health educational program on oral hygiene status and oral health-related quality of life (OHRQoL) among children diagnosed with β-thalassemia.

Detailed Description

Benefits to the patient

  • The clinical examination and OHRQoL assessments provide a well-established foundation to plan the oral-dental treatment for each individual.
  • Improved awareness among β-thalassemia patients and caregivers regarding oral hygiene practices and the importance of regular dental visits may contribute to better oral health outcomes and enhanced overall quality of life.

Benefits to the community

  • Provide valuable epidemiological data on the oral health status and oral health-related quality of life in children with β-thalassemia.
  • Assist dental professionals, healthcare providers, and policymakers in planning targeted preventive strategies and integrating oral health care into the comprehensive management of thalassemia.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
8 Years to 10 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Children having medical records confirmed of β-thalassemia diagnosis.
  • Age range between 8-10 years old.
  • Have acceptable cooperation

Exclusion Criteria

  • Children with Cognitive impairment.
  • Participants in another oral health education program or clinical study within the past 6 months will be excluded.
  • Unstable clinical condition as judged by the treating physician

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mariam Mohamed Mohamed Diaa eldin Shafie

Principal Investigator

Cairo University

Similar Trials